Effect of Discontinuing vs Continuing ACEIs and ARBs in Patients Admitted With COVID-19

This randomized clinical trial compares the effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) on days alive and out of the hospital at 30 days among patients with COVID-19 taking the drugs prior to hospitalization.
Source: JAMA - Category: General Medicine Source Type: research